CON Approved for BriovaRx Infusion Services

We served as lead counsel to BriovaRx Infusion Services (BriovaRx) in obtaining a Certificate of Need (CON) to expand its scope of home infusion services in Middle Tennessee from IVIG-only to all infusion medications dispensed by BriovaRx pharmacies. The application was unanimously approved by state regulators. Bass, Berry & Sims previously represented BriovaRx (formerly AxelaCare) in obtaining state-wide CON approval to establish a home health organization limited to IVIG infusions.

BriovaRx Infusion Services is the fourth largest provider of home infusion medications and services in the U.S. and is part of the Optum family of companies, owned by UnitedHealth Group, Inc. (NYSE: UNH).

You Also May Be Interested In:

  • Representation of Bravo Wellness, a national provider of employee wellness solutions and portfolio company of ABS Capital, in its sale to Medical Mutual, a health insurance company based in Ohio

    We represented Bravo Wellness, an ABS Capital portfolio company, in its sale to Medical Mutual, a health insurance company based...
    Client Type: Private Company
  • Representation of MyHealthDirect, a digital care coordination platform, in its sale to Experian Health

    We represented MyHealthDirect, a provider of digital care coordination platform that optimizes scheduling for providers, payers and consumers, in its...
    Client Type: Private Company
  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company